| Proliferative HCC (n = 63) | Non-proliferative HCC (n = 61) | p value |
---|---|---|---|
Rim APHE | Â | Â | 0.02* |
 Absent | 51 (80.95%) | 58 (95.08%) |  |
 Present | 12 (19.05%) | 3 (4.92%) |  |
Nonperipheral washout | Â | Â | 0.89 |
 Absent | 24 (38.10%) | 24 (39.34%) |  |
 Present | 39 (61.90%) | 37 (60.66%) |  |
Capsule | Â | Â | 0.24 |
 Absent | 26 (41.27%) | 19 (31.15%) |  |
 Present | 37 (58.73%) | 42 (68.85%) |  |
Peritumoral enhancement | Â | Â | 0.27 |
 Absent | 56 (88.89%) | 50 (81.97%) |  |
 Present | 7 (11.11%) | 11 (18.03%) |  |
Tumor margin | Â | Â | 0.09 |
 Smooth | 33 (52.38%) | 41 (67.21%) |  |
 Non-smooth | 30 (47.62%) | 20 (32.79%) |  |
LR-RADS categorization | Â | Â | 0.005* |
 LR-M | 12 (19.05%) | 3 (4.92%) |  |
 LR-TIV | 4 (6.35%) | 1 (1.64%) |  |
 LR-3 | 7 (11.11%) | 2 (3.28%) |  |
 LR-4 | 13 (20.63%) | 10 (16.39%) |  |
 LR-5 | 27 (42.86%) | 45 (73.77%) |  |